Canntab Reaches Agreement with Innovative Bioinformatics Com

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and...

Related Keywords

Frankfurt , Brandenburg , Germany , Canada , Toronto , Ontario , London , City Of , United Kingdom , Canadian , John Tse , Larry Latowsky , Company Or Canntab , Canntab Therapeutics Limited , Cannabis Research , Frankfurt Stock Exchange , Canntab Therapeutics , Technologies Inc , Katz Group Rexall , Canadian Community Pharmacies , Health Canada , Canadian Securities Exchange , London Drug Vice President , Cannabis Standard Processing , Medical Purposes License , Cannabis Research License , Industrial Hemp License , Cannabis , Otc , Mallcap , Licensing ,